Insight Pharma Reports, our partner for publishing market and technology assessments, has pushed out another H.M. Pharma Consultancy Report: Data Mining in Drug Development and Translational Medicine. It discusses data mining in the preclinical and clinical stages of drug development, as well as postmarketing surveillance issues. You can find details here. To buy the report, please contact Insight Pharma.
ThirdSpace, our next-generation patent database platform, has received some press coverage recently, and we have seen the level of attention rising; people are realizing that this is not just another patent collection but a highly annotated and interactive knowledge repository that is heavy with metadata not to be found elsewhere. The first module, to which we internally refer to as Redwing, covers ophthalmology – a dynamically growing sector of the life science industry which can be cleanly addressed by marketing efforts: whatever happens on or in the eye just belongs to the ophthalmologist.
Our core competency is not in information technology or web programming but in the management and application of life science knowledge, and so we are talking to companies who are experts in these fields. Obviously there is not much that I could disclose here at this time, but lets just say that things are moving in the right direction. Meanwhile, we are updating our coverage; ocular pharmacology patent updates for the second quarter of 2009 are just being added. More about this later.